Table 2.
Unadjusted mean (SD) RAND 36-item Health Survey subscale scores at each interview, by diagnostic group
| DCIS | EIBC | Controls | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T4 | T1 | T2 | T3 | T4 | T1 | T2 | T3 | T4 | |
| PF | 78.48a (23.17) | 80.06 (23.95) | 81.53 (23.09) | 80.50 (24.02) | 76.46b (22.56) | 75.66b (25.15) | 77.68b (23.94) | 76.33b (25.34) | 84.07a,b (21.13) | 84.10b (21.66) | 83.48b (21.40) | 83.81b (20.15) |
| RP | 42.26a,c (42.92) | 71.25c (40.29) | 75.00 (38.60) | 74.71 (38.67) | 32.74b,c (39.92) | 55.74b,c (44.60) | 66.86b (42.55) | 70.25b (41.80) | 78.56a,b (35.82) | 77.29b (35.53) | 75.48b (37.39) | 78.17b (36.01) |
| RE | 74.28a (39.61) | 82.78 (32.00) | 82.77 (34.03) | 86.02 (31.69) | 71.42b (39.17) | 80.35b (35.56) | 84.76 (31.76) | 83.48 (34.05) | 87.20a,b (28.90) | 77.29b (35.53) | 86.14 (29.87) | 85.21 (30.94) |
| E/F | 55.51a (23.45) | 61.75c (23.23) | 64.76c (21.62) | 63.39 (22.04) | 51.99b (22.69) | 55.51b,c (25.72) | 58.34b,c (23.97) | 60.57 (24.00) | 63.21a,b (19.97) | 61.72b (20.25) | 62.69b (19.86) | 62.32 (20.22) |
| EWB | 77.61 (17.80) | 80.13 (15.91) | 82.36 (15.75) | 81.56 (15.30) | 76.50b (18.34) | 79.97 (17.40) | 80.99 (17.33) | 82.23b (16.78) | 80.76b (14.98) | 80.41 (15.79) | 81.01 (14.29) | 79.03b (16.91) |
| SF | 78.53a,c (25.86) | 85.97c (23.02) | 87.57 (21.93) | 87.57 (21.06) | 72.36b,c (28.29) | 79.52b,c (26.44) | 83.71 (23.88) | 85.92 (22.80) | 88.16a,b (21.15) | 87.42b (22.42) | 86.82 (21.36) | 86.77 (21.53) |
| Pain | 70.35a (25.41) | 77.08 (22.81) | 77.16 (23.43) | 73.58 (25.11) | 66.66b (25.03) | 71.90b (25.58) | 72.81 (24.38) | 73.25 (24.18) | 76.07a,b (22.15) | 77.14b (24.11) | 76.63 (22.73) | 76.32 (23.91) |
| GH | 70.68 (21.51) | 70.93 (18.76) | 71.52 (19.45) | 69.72 (22.24) | 67.98b (21.48) | 67.17b (22.46) | 68.43b (22.86) | 67.99b (22.55) | 73.20b (20.33) | 73.81b (20.80) | 73.57b (20.58) | 73.42b (21.08) |
SD standard deviation, DCIS ductal carcinoma in situ, EIBC early invasive breast cancer (stages I and IIA), T1 first interview 4–6 weeks after definitive surgical treatment, T2 second interview 6-month follow-up, T3 third interview 1-year follow-up, T4 fourth interview 2-year follow-up, PF physical functioning, RP role limitations due to physical problems, RE role limitations due to emotional problems, E/F energy/fatigue, EWB emotional well being, SF social functioning, GH general health
Scores range from 0 to 100
Analysis of variance post-hoc comparisons between DCIS patients and controls significant at P < 0.05 at the same interview
Analysis of variance post -hoc comparisons between EIBC patients and controls significant at P < 0.05 at the same interview
Analysis of variance post -hoc comparisons between DCIS and EIBC patients significant at P < 0.05 at the same interview